Literature DB >> 9513755

Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats.

J Semba1, C Mataki, S Yamada, M Nankai, M Toru.   

Abstract

BACKGROUND: The association between smoking and depression has been widely investigated. Smoking cessation is known to induce depression to a variable extent, and patients with a history of depression are more likely to experience depressive symptoms. To investigate the hypothesis that nicotine may have an antidepressantlike effect, we used learned helpless rats as an animal model of depression.
METHODS: Learned helplessness was produced according to our previous method. Learned helpless rats were implanted with nicotine and escape test was performed at 7 and 14 days after the implantation.
RESULTS: The number of escape failure in the rats receiving 1.5 mg/kg/day of nicotine was significantly reduced (p < .05) compared to control at day 14. Furthermore, this effect was blocked when the nicotinic receptor antagonist mecamylamine was coadministered.
CONCLUSIONS: These results suggest that chronic nicotine may act as an antidepressant, probably via nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513755     DOI: 10.1016/s0006-3223(97)00477-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  50 in total

Review 1.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

2.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

3.  Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray.

Authors:  Roger A Kroes; Jeffrey Burgdorf; Nigel J Otto; Jaak Panksepp; Joseph R Moskal
Journal:  Behav Brain Res       Date:  2007-03-25       Impact factor: 3.332

Review 4.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

5.  Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression.

Authors:  Alan P Kozikowski; J Brek Eaton; Krishna Mohan Bajjuri; Sheela K Chellappan; Yihua Chen; Sudhakar Karadi; Rong He; Barbara Caldarone; Michael Manzano; Po-Wai Yuen; Ronald J Lukas
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

6.  Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests.

Authors:  Arya Haj-Mirzaian; Nastaran Kordjazy; Arvin Haj-Mirzaian; Sattar Ostadhadi; Mehdi Ghasemi; Shayan Amiri; Mehrdad Faizi; AhmadReza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2015-07-15       Impact factor: 4.530

7.  Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.

Authors:  Tanuja Bordia; Carla Campos; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2010-03-03       Impact factor: 4.030

8.  Cigarette Smoking and Tryptophan Hydroxylase 2 mRNA in the Dorsal Raphe Nucleus in Suicides.

Authors:  Helene Bach; Victoria Arango; Suham A Kassir; Andrew J Dwork; J John Mann; Mark D Underwood
Journal:  Arch Suicide Res       Date:  2016-03-08

Review 9.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 10.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.